|
STIP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.239900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.308420E-02 |
| Normal-vs-Stage2 |
7.121700E-02 |
| Normal-vs-Stage3 |
6.04109999999825E-05 |
| Normal-vs-Stage4 |
1.198310E-03 |
| Stage1-vs-Stage2 |
8.029000E-01 |
| Stage1-vs-Stage3 |
2.355600E-03 |
| Stage1-vs-Stage4 |
7.683600E-02 |
| Stage2-vs-Stage3 |
2.026300E-02 |
| Stage2-vs-Stage4 |
1.336420E-01 |
| Stage3-vs-Stage4 |
6.442000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.760910E-03 |
| Normal-vs-AfricanAmerican |
5.439500E-02 |
| Normal-vs-Asian |
8.881600E-02 |
| Caucasian-vs-AfricanAmerican |
8.569600E-01 |
| Caucasian-vs-Asian |
2.299200E-01 |
| AfricanAmerican-vs-Asian |
5.503800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.802000E-04 |
| Normal-vs-Female |
4.638100E-03 |
| Male-vs-Female |
1.649810E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.783900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.412400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.985370E-04 |
| Normal-vs-Age(81-100Yrs) |
9.969900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.478300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.923200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.422200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.534600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.696400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.934600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.381000E-03 |
| Classical-VS-Follicular |
2.292800E-01 |
| Classical-VS-Other |
3.872200E-01 |
| Classical-VS-Normal |
9.180200E-03 |
| Tall-VS-Follicular |
6.831600E-02 |
| Tall-VS-Other |
7.006000E-01 |
| Tall-VS-Normal |
2.13379999999264E-05 |
| Follicular-VS-Other |
7.531000E-01 |
| Follicular-VS-Normal |
2.142400E-03 |
| Other-VS-Normal |
1.090390E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.799800E-03 |
| Normal-vs-N1 |
1.573930E-04 |
| N0-vs-N1 |
4.870300E-02 |
|
|
